| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Bourque Michael J. | EVP, CFO & Treasurer | C/O INOGEN, INC., 500 CUMMINGS CENTER, SUITE 2800, BEVERLY | /s/ Mary Wright, as Attorney-in-Fact | 03 Mar 2026 | 0001638420 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INGN | Common Stock | Award | $5,331 | +874 | +1.8% | $6.10 | 50,020 | 01 Mar 2026 | Direct | F1 |
| transaction | INGN | Common Stock | Options Exercise | $0 | +25,000 | +50% | $0.000000 | 75,020 | 01 Mar 2026 | Direct | |
| transaction | INGN | Common Stock | Tax liability | $56,962 | -9,338 | -12% | $6.10 | 65,682 | 01 Mar 2026 | Direct | F2 |
| transaction | INGN | Common Stock | Award | $0 | +28,875 | +44% | $0.000000 | 94,557 | 01 Mar 2026 | Direct | F3 |
| transaction | INGN | Common Stock | Tax liability | $64,752 | -10,615 | -11% | $6.10 | 83,942 | 01 Mar 2026 | Direct | F4 |
| transaction | INGN | Common Stock | Options Exercise | $0 | +17,007 | +20% | $0.000000 | 100,949 | 01 Mar 2026 | Direct | |
| transaction | INGN | Common Stock | Tax liability | $38,753 | -6,353 | -6.3% | $6.10 | 94,596 | 01 Mar 2026 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INGN | Restricted Stock Unit | Award | $0 | +39,000 | $0.000000 | 39,000 | 27 Feb 2026 | Common Stock | 39,000 | Direct | F5, F6 | ||
| transaction | INGN | Restricted Stock Unit | Options Exercise | $0 | -25,000 | -50% | $0.000000 | 25,000 | 01 Mar 2026 | Common Stock | 25,000 | Direct | F5, F7 | |
| transaction | INGN | Restricted Stock Unit | Options Exercise | $0 | -17,007 | -33% | $0.000000 | 34,013 | 01 Mar 2026 | Common Stock | 17,007 | Direct | F5, F8 |
| Id | Content |
|---|---|
| F1 | Shares acquired through the Company's 2014 Employee Stock Purchase Plan. |
| F2 | The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026. |
| F3 | The reported securities represent shares earned and vested on March 1, 2026 based on achievement of the financial performance conditions for the 2025 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on March 4, 2024. |
| F4 | The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on March 4, 2024 and vested on March 1, 2026. |
| F5 | Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. |
| F6 | Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date. |
| F7 | 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date. |
| F8 | 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date. |